BCE News Alert BCE Inc (BCE) 44.74 02/14/2015 00:34:11

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:34 AM

BCE Inc (BCE) 44.74 $BCE

Telus Misses Q4 Earnings & Revenues, Offers 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:32AM CST
Telus Corp. (TU) reported dismal fourth-quarter 2014 numbers with both the top line and the bottom line missing the Zacks Consensus Estimate.
BCE: 44.74 (+0.14), TU: 34.83 (+0.01), VG: 4.37 (+0.02), CHT: 30.31 (-0.33)

Buy These Top 3 Buy-Rated Dividend Stocks Today: HR, BCE, BMR
at The Street - Wed Feb 11, 9:38AM CST
These 3 dividend stocks are rated a Buy by TheStreet
BMR: 22.85 (-0.13), BCE: 44.74 (+0.14), HR: 28.69 (-0.08)

Bell Canada renews Medium Term Notes program
PR Newswire - Tue Feb 10, 4:26PM CST
Bell Canada (Bell) today announced the filing of a prospectus supplement to a short form base shelf prospectus dated November14, 2014 with the various securities regulatory authorities in all the provinces of Canada and with the Securities and Exchange Commission (SEC) in the United States to renew Bell's Medium Term Notes (MTN) program.
BCE.TO: 55.80 (+0.03), BCE: 44.74 (+0.14)

Look for Shares of BCE Inc to Potentially Rebound after Yesterday's 2.89% Sell Off
Comtex SmarTrend(R) - Mon Feb 09, 4:04PM CST
BCE Inc (NYSE:BCE) traded in a range yesterday that spanned from a low of $43.62 to a high of $44.71. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $44.93 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCE: 44.74 (+0.14)

Watch for BCE Inc to Potentially Rebound After Falling 2.89% Yesterday
Comtex SmarTrend(R) - Mon Feb 09, 4:04PM CST
BCE Inc (NYSE:BCE) traded in a range yesterday that spanned from a low of $43.62 to a high of $44.71. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $44.93 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCE: 44.74 (+0.14)

10 Stocks Building Wealth Through Higher Dividends
Dividends4Life - at Seeking Alpha - Fri Feb 06, 4:16PM CST

DPS: 76.95 (-1.35), TE: 19.59 (-0.32), DNKN: 46.70 (-0.69), CINF: 52.46 (+0.27), NUS: 56.92 (-1.30), BCE: 44.74 (+0.14), SEP: 55.10 (+0.19), XRX: 13.77 (+0.20), UNP: 122.60 (-1.23), SUN: 50.34 (+0.22)

BCE pulls back from record high, down 5%
Seeking Alpha - at Seeking Alpha - Fri Feb 06, 2:41PM CST

RCI: 36.71 (+0.59), SJR: 23.92 (+0.13), BCE: 44.74 (+0.14), TU: 34.83 (+0.01)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
AXE: 76.07 (+0.44), BIO: 118.36 (+0.79), BCE: 44.74 (+0.14), BITA: 62.95 (+2.85)

BCE Lags Earnings by a Penny, Beats Revenues; Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:15AM CST
BCE Inc. (BCE) reported mixed financial results for the fourth quarter of 2014.
RCI: 36.71 (+0.59), BCE: 44.74 (+0.14), TU: 34.83 (+0.01), VG: 4.37 (+0.02)

BCE's (BCE) CEO George Cope on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 1:22PM CST

BCE: 44.74 (+0.14)

BCE declares $0.65 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 6:48AM CST

BCE: 44.74 (+0.14)

BCE beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 6:01AM CST

BCE: 44.74 (+0.14)

BCE reports 2014 Q4 and full-year results, announces 2015 financial outlook - Common share dividend increased 5.3% to $2.60 per year
CNW Group - Thu Feb 05, 6:00AM CST
This news release contains forward-looking statements. For a description of the related risk factors and assumptions please see the section entitled "Caution Concerning Forward-Looking Statements" later in this release.
BCE.TO: 55.80 (+0.03), BCE: 44.74 (+0.14)

16.5% Advantage For 5 Technology Lowest-Priced, High-Yield January Dividend Dogs
Fredrik Arnold - at Seeking Alpha - Wed Feb 04, 5:58PM CST

PT: 0.83 (+0.04), T: 34.66 (+0.05), FTR: 8.38 (+0.01), BCOM: 15.76 (unch), BCE: 44.74 (+0.14), CNSL: 24.09 (+0.15), WIN: 8.94 (+0.06), VOD: 35.85 (+0.14), VIV: 18.95 (+0.51), CTL: 39.46 (+0.17)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:30PM CST

FIS: 66.52 (+0.33), PRGO: 150.90 (+0.22), LAZ: 50.90 (+0.18), CHTR: 177.88 (+0.85), LQDT: 9.52 (+0.09), CFX: 52.02 (+3.84), KORS: 73.27 (+1.72), OZM: 11.93 (-0.14), PTEN: 18.14 (+1.13), DLPH: 78.70 (+0.64), DNKN: 46.70 (-0.69), DFT: 31.83 (-0.17), AMSC: 0.80 (+0.02), APO: 23.70 (+0.36), SNCR: 43.89 (+1.06), PRLB: 74.00 (+2.60), CSL: 94.14 (-0.09), SIRI: 3.83 (-0.07), PBH: 39.07 (+0.27), COTY: 22.03 (unch), RSTI: 24.12 (+0.20), IT: 81.53 (+1.64), ADS: 286.61 (+1.70), AINV: 7.71 (+0.15), AZN: 69.96 (+0.20), BCE: 44.74 (+0.14), NGD: 3.73 (-0.04), EL: 82.49 (+1.58), BCO: 25.73 (+0.18), RFP: 19.03 (+0.40), ODFL: 76.25 (+0.96), BDX: 143.71 (+0.72), GRA: 101.61 (+1.69), SNA: 145.40 (+0.71), BR: 52.59 (-0.29), BLL: 74.93 (+0.89), GRUB: 39.93 (+1.71), SBH: 33.10 (+0.28), ARW: 61.98 (+0.78), ETR: 79.12 (-1.53), BDC: 87.78 (+0.61), IVC: 17.13 (+0.15), CMI: 139.04 (+2.41), S: 5.23 (+0.08), PPL: 34.69 (-0.16), NUS: 56.92 (-1.30), MMP: 80.41 (-0.86), MMS: 59.14 (+0.12), MSCI: 57.20 (unch), MDSO: 46.58 (+1.48), ICE: 233.22 (-1.21), FBP: 6.35 (-0.02), LIOX: 5.57 (+0.10), CI: 114.47 (-0.51), PM: 82.87 (-0.82), EQT: 81.18 (+0.43), GPI: 84.34 (-0.74), ABB: 21.34 (+0.27), GPK: 15.41 (+0.29), GLT: 24.89 (+0.04), EQM: 88.04 (+0.96)

10 Technology Dividend Dogs Tap 14% To 52% January Upsides
Fredrik Arnold - at Seeking Alpha - Wed Feb 04, 2:27PM CST

FTR: 8.38 (+0.01), CMTL: 35.26 (+0.63), BCOM: 15.76 (unch), LMOS: 17.98 (-0.14), GRMN: 55.93 (+0.02), ELNK: 4.54 (+0.05), CNSL: 24.09 (+0.15), ISIL: 15.30 (-0.25), WIN: 8.94 (+0.06), VOD: 35.85 (+0.14), VIV: 18.95 (+0.51), PT: 0.83 (+0.04), T: 34.66 (+0.05), BCE: 44.74 (+0.14), TU: 34.83 (+0.01), CTL: 39.46 (+0.17), LXK: 44.70 (+0.43)

Will BCE Disappoint Earnings Estimates This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 2:40PM CST
Canada's leading communications service provider, BCE Inc. (BCE), is slated to report its fourth-quarter 2014 quarterly numbers before the opening bell on Feb 5.
CHTR: 177.88 (+0.85), BCE: 44.74 (+0.14), CTL: 39.46 (+0.17), JNPR: 23.84 (+0.19)

Another Bell Fibe first: Innovative "Restart" feature for TV shows already in progress
CNW Group - Mon Feb 02, 8:00AM CST
Enhanced Fibe TV menu and channel guide also launching
BCE.TO: 55.80 (+0.03), BCE: 44.74 (+0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Dickinson Brands Celebrates Witch Hazel Legacy with Event

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Angels on Call Sets Benchmark for Specialized Homecare

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

New Chapter Recovery Garners Key Accreditations

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...